Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119095422 | 11909542 | 2 | F | 2012 | 20160705 | 20160112 | 20160713 | EXP | US-ASTRAZENECA-2016SE00489 | ASTRAZENECA | 84.00 | YR | F | Y | 0.00000 | 20160713 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119095422 | 11909542 | 1 | PS | SYMBICORT | BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE | 1 | Respiratory (inhalation) | DOSE AND FREQUENCY UNKNOWN UNKNOWN | Y | 21929 | |||||||||
| 119095422 | 11909542 | 2 | SS | ADVAIR HFA | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | Unknown | 500/50 MCG | U | 0 | INHALATION POWDER | ||||||||
| 119095422 | 11909542 | 3 | SS | ADVAIR HFA | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | Unknown | 500/50 MCG | U | 0 | INHALATION POWDER | ||||||||
| 119095422 | 11909542 | 4 | SS | SEREVENT DISKUS | SALMETEROL XINAFOATE | 1 | Unknown | 1 PUFF TWO TIMES A DAY | U | U | 52P0816 | 0 | INHALATION POWDER | ||||||
| 119095422 | 11909542 | 5 | SS | SEREVENT DISKUS | SALMETEROL XINAFOATE | 1 | Unknown | 1 PUFF TWO TIMES A DAY | U | U | 52P0816 | 0 | INHALATION POWDER | ||||||
| 119095422 | 11909542 | 6 | SS | SEREVENT DISKUS | SALMETEROL XINAFOATE | 1 | Unknown | 1 PUFF TWO TIMES A DAY | U | U | 52P0816 | 0 | INHALATION POWDER | ||||||
| 119095422 | 11909542 | 7 | SS | FLOVENT | FLUTICASONE PROPIONATE | 1 | Unknown | Y | 0 | INHALATION VAPOUR, LIQUID | |||||||||
| 119095422 | 11909542 | 8 | SS | NASONEX | MOMETASONE FUROATE | 1 | Unknown | Y | 0 | ||||||||||
| 119095422 | 11909542 | 9 | C | EVISTA | RALOXIFENE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 119095422 | 11909542 | 10 | C | ALLEGRA | FEXOFENADINE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 119095422 | 11909542 | 11 | C | TEMAZEPAM. | TEMAZEPAM | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 119095422 | 11909542 | 2 | Anaphylactic reaction |
| 119095422 | 11909542 | 3 | Adverse drug reaction |
| 119095422 | 11909542 | 4 | Anaphylactic reaction |
| 119095422 | 11909542 | 5 | Adverse drug reaction |
| 119095422 | 11909542 | 6 | Dyspnoea |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 119095422 | 11909542 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 119095422 | 11909542 | Back pain | |
| 119095422 | 11909542 | Drug hypersensitivity | |
| 119095422 | 11909542 | Dysphagia | |
| 119095422 | 11909542 | Hiccups | |
| 119095422 | 11909542 | Lacrimation increased | |
| 119095422 | 11909542 | Macular degeneration | |
| 119095422 | 11909542 | Osteoporosis | |
| 119095422 | 11909542 | Pulmonary function test decreased | |
| 119095422 | 11909542 | Salivary hypersecretion |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 119095422 | 11909542 | 2 | 2009 | 0 | ||
| 119095422 | 11909542 | 3 | 2009 | 0 | ||
| 119095422 | 11909542 | 4 | 1975 | 0 | ||
| 119095422 | 11909542 | 5 | 1975 | 0 | ||
| 119095422 | 11909542 | 6 | 1975 | 0 | ||
| 119095422 | 11909542 | 7 | 1975 | 2015 | 0 |